AJMC July 19, 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School, discusses ways that wearable devices and health apps are improving value-based care.
Artificial intelligence (AI) is important to value-based care by contributing to better outcomes, patient adherence, and lowering costs, says Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School.
This transcript has been lightly edited.
Transcript
Given the ongoing debate about AI’s role in clinical settings, how do you foresee the balance between AI and physician decision-making evolving in the context of value-based care?
When AI acts as an augmentative tool rather than a replacement for human expertise, that’s where this magic is made. So, decision...